Takeda's ORZEYFUL Wins FDA Approval As First Orexin Therapy For Narcolepsy Type 1; U.S. Launch Planned Following DEA Scheduling

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.